MaxCyte Ownership | Who Owns MaxCyte?


OverviewForecastRevenueFinancialsChartTranscripts

MaxCyte Ownership Summary


MaxCyte is owned by 11.10% institutional investors, 1.23% insiders, and 87.67% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 9.59% of MXCT shares. RGI UK Listed Smaller Coms B Acc is the top mutual fund, with 3.10% of its assets in MaxCyte shares.

MXCT Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockMaxCyte11.10%1.23%87.67%
SectorHealthcare Stocks 279.42%10.64%-190.05%
IndustryMedical Device Stocks32.07%10.57%57.35%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de10.20M9.59%$22.24M
Cadian capital management, lp8.91M8.38%$19.43M
Blackrock8.14M7.82%$31.92M
Mirabella financial services llp6.60M6.20%$14.39M
Vanguard group5.43M5.17%$22.59M
Vitruvian partners llp5.04M4.74%$10.99M
Morgan stanley4.64M4.46%$18.19M
Mudita advisors llp3.37M3.17%$7.35M
Fmr3.14M2.98%$13.05M
Geode capital management2.48M2.36%$10.31M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Vitruvian partners llp5.04M6.70%$10.99M
Mudita advisors llp3.37M2.46%$7.35M
River & mercantile asset management llp1.97M2.14%$7.78M
Mirabella financial services llp6.60M1.48%$14.39M
Cadian capital management, lp8.91M1.09%$19.43M
Bleichroeder lp250.00K0.13%$521.93K
Epacria capital partners62.13K0.11%$135.45K
Willis investment counsel405.47K0.11%$1.69M
Entrypoint capital61.28K0.07%$133.59K
Rice hall james & associates417.85K0.05%$910.90K

Top Buyers

HolderShares% AssetsChange
Mirabella financial services llp6.60M1.48%2.90M
Blackrock funding, inc. /de10.20M0.00%2.03M
Morgan stanley4.64M0.00%1.12M
Axa986.90K0.01%986.90K
Blackrock8.14M0.00%912.79K

Top Sellers

HolderShares% AssetsChange
Swedbank ab---1.39M
Millennium management1.38M0.00%-1.36M
Arrowmark colorado83.66K0.00%-1.24M
Portolan capital management---1.14M
Ameriprise financial---1.12M

New Positions

HolderShares% AssetsChangeValue
Axa986.90K0.01%986.90K$4.11M
Schroder investment management group136.95K0.00%136.95K$298.54K
Los angeles capital management63.33K0.00%63.33K$138.06K
Dynamic technology lab private18.22K0.01%18.22K$40.00K
Bnp paribas arbitrage, snc13.52K-13.52K$56.23K

Sold Out

HolderChange
Capital performance advisors llp-12.00
Nelson, van denburg & campbell wealth management group-17.00
Advisor group-125.00
Physician wealth advisors-202.00
Lindbrook capital-237.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20256-94.96%11,761,193-83.77%110.23%3-95.38%2-93.33%
Dec 31, 2024112-6.67%62,742,646-8.73%591.40%61-1.61%27-6.90%
Sep 30, 20241205.26%68,740,2960.59%651.52%626.90%29-21.62%
Jun 30, 2024114-7.32%68,339,9382.19%651.58%583.57%37-19.57%
Mar 31, 20241233.36%66,873,3672.47%641.62%56-17.65%4653.33%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
RGI UK Listed Smaller Coms B Acc3.30M3.10%-
Vanguard US Total Market Shares ETF2.92M2.76%-30.16K
Vanguard Total Stock Mkt Idx Inv2.81M2.64%-
Unicorn AIM VCT Ord2.49M2.33%-
iShares Russell 2000 ETF2.41M2.26%-45.78K
AXA Framlington Health Fund - R Income2.20M2.07%612.45K
Vanguard Institutional Extnd Mkt Idx Tr1.70M1.60%4.72K
Swedbank Robur USA A1.36M1.28%-30.00K
IFSL Marlborough UK Micro Cap Gr A Acc1.35M1.27%-
Fidelity Small Cap Index1.09M1.03%7.41K

Recent Insider Transactions


DateNameRoleActivityValue
Aug 13, 2025Swirsky Douglas J CHIEF FINANCIAL OFFICERBuy$64.50K
Aug 13, 2025Masoud Maher President and CEOBuy$102.92K
Aug 13, 2025Erck Stanley C-Buy$137.22K
Aug 13, 2025DOUGLAS RICHARD-Buy$111.04K
Aug 13, 2025Brooke William W-Buy$64.50K

Insider Transactions Trends


DateBuySell
2025 Q35-
2025 Q2--
2025 Q1-5
2024 Q4-7
2024 Q3-9

MXCT Ownership FAQ


Who Owns MaxCyte?

MaxCyte shareholders are primarily institutional investors at 11.10%, followed by 1.23% insiders and 87.67% retail investors. The average institutional ownership in MaxCyte's industry, Medical Device Stocks, is 32.07%, which MaxCyte falls below.

Who owns the most shares of MaxCyte?

MaxCyte’s largest shareholders are Blackrock funding, inc. /de (10.2M shares, 9.59%), Cadian capital management, lp (8.91M shares, 8.38%), and Blackrock (8.14M shares, 7.82%). Together, they hold 25.79% of MaxCyte’s total shares outstanding.

Does Blackrock own MaxCyte?

Yes, BlackRock owns 7.82% of MaxCyte, totaling 8.14M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 31.92M$. In the last quarter, BlackRock increased its holdings by 912.79K shares, a 12.63% change.

Who is MaxCyte’s biggest shareholder by percentage of total assets invested?

Vitruvian partners llp is MaxCyte’s biggest shareholder by percentage of total assets invested, with 6.70% of its assets in 5.04M MaxCyte shares, valued at 10.99M$.

Who is the top mutual fund holder of MaxCyte shares?

RGI UK Listed Smaller Coms B Acc is the top mutual fund holder of MaxCyte shares, with 3.10% of its total shares outstanding invested in 3.3M MaxCyte shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools